It is the fourth leading cause of death in the United States, affecting nearly 16 million people, but for many Americans, chronic obstructive pulmonary disease, or COPD, still remains a mystery. That’s why in 2017, at the request of Congress, the NHLBI led a year-long, multi-team effort to figure out what it would take to relieve the burden of this...
Fifty years of advancement into an ever-greater understanding of lung illnesses have whet the interest of the NHLBI’s Division of Lung Diseases (DLD) in precision medicine.
Teens with a single ventricle heart defect significantly improved their capacity to sustain moderate exercise by taking an oral medication. The trial results, researchers say, represent a milestone in the care for those who have undergone the Fontan procedure, a palliative operation for this patient
Researchers have discovered a new biological pathway that promotes chronic inflammation and may help explain why sedentary people have an increased risk for heart disease and strokes.
Researchers from dozens of leading institutions around that nation have proposed new criteria for diagnosing chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.
An innovative method of measuring the immune system’s white blood cells from a small blood sample could provide significantly more prognostic information about patients with sepsis.
mplementation, the adoption of research findings in clinicians’ everyday practice, can be the Achilles’s heel of health care advancements and improvement in patients’ outcomes.
Women who give birth to five or more children have a higher risk for heart disease, obesity, high blood pressure, and are less likely to be physically active, according to a recent study.
Lung regeneration and repair has been a long-standing interest of NHLBI, since the creation of the Division of Lung Diseases (DLD) 50 years ago
Researchers are reporting development of a new delivery tool for gene-editing that targets a broad range of lung diseases including cystic fibrosis, COPD, and asthma.